JANE STREET GROUP, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$113,000
-64.2%
11,161
-66.0%
0.00%
-100.0%
Q4 2017$316,000
+146.9%
32,858
+201.5%
0.00%0.0%
Q3 2016$128,000
-62.1%
10,899
-7.6%
0.00%
-50.0%
Q4 2015$338,000
-72.1%
11,796
-72.3%
0.00%
-75.0%
Q3 2015$1,213,000
+6.5%
42,615
+34.4%
0.01%0.0%
Q2 2015$1,139,000
+408.5%
31,707
+722.1%
0.01%
+300.0%
Q1 2015$224,000
-28.0%
3,857
-47.7%
0.00%0.0%
Q4 2014$311,000
+45.3%
7,370
+33.5%
0.00%0.0%
Q3 2014$214,0005,5200.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
Orbimed Advisors 3,028,354$30,526,0000.37%
Engineers Gate Manager LP 96,105$969,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 61,600$621,0000.06%
GAM Holding AG 83,940$846,0000.03%
SHELL ASSET MANAGEMENT CO 90,282$910,0000.02%
SFMG, LLC 11,994$107,0000.02%
QS Investors, LLC 159,133$1,604,0000.02%
Winslow, Evans & Crocker, Inc. 4,060$42,0000.01%
PANAGORA ASSET MANAGEMENT INC 285,646$2,879,0000.01%
PEAK6 Investments LLC 225,800$2,276,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders